MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GA-01-0000372
Market Cap
₹30.76 Cr
GKB · NSE
Share Price
₹60.50
-0.87% today
Revenue
₹149 Cr
FY 2025-26 · +36.8% YoY
EBITDA
₹6.77 Cr
Margin 4.5%
Net Profit
₹2.75 Cr
FY 2025-26 · +138.8% YoY
P/E (TTM)
6.1x
P/B 0.6x
ROE
8.9%
ROCE 10.8%
Debt / Equity
0.25
Interest cover 75.6x
About GKB Ophthalmics Limited
Data last updated:
GKB Ophthalmics Limited is a public limited company based in Mapusa, Goa, India. It operates in the lifestyle products and accessories manufacturing segment of the home and lifestyle products sector. It was incorporated on 10 December 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN L26109GA1981PLC000469. Its GSTIN is 30AAACG7070R1ZE (Goa). It is a listed company as per MCA records. Its shares are listed on BSE: 533212 and NSE: GKB.
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹5.04 Cr. It is led by directors including Krishna Gopal Gupta (Managing Director) and Cedric Lobo (Whole-Time Director).
Its last annual general meeting (AGM) was held on 21 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 16A Tivim Industrial Estate Mapusa, Goa, India – 403526.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹149.06 Cr, a growth of 36.8% compared to the previous year. For the same year it recorded a net profit of ₹2.75 Cr (net margin 1.8%) and EBITDA of ₹6.77 Cr (EBITDA margin 4.5%). The net worth stands at ₹52.83 Cr (up 1.2% YoY). Total assets are valued at ₹71.06 Cr (down 4.3% YoY).
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: GKB Ophthalmics. As per MCA filings, the company has open charges of ₹14.44 Cr and satisfied charges of ₹8.06 Cr on record. Court records list 19 cases involving the company, including 11 filed by the company and 8 filed against it; 4 cases are pending. The company has 29 deals on record (29 market trades); the latest was in September 2026. The company has 17 MSME Form 1 returns on record between 2019 and 2024, listing 1,966 overdue payments to 92 micro and small suppliers.
GKB Ophthalmics Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GA-01-0000372). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gkb.net.
Company details
CIN L26109GA1981PLC000469
Registration Number 000469
Incorporation Date 10 December 1981
ROC Goa
Listing Status Listed - Listed on NSE (GKB); Listed on BSE (533212)
Company Status Active
Date of Last AGM 21 August 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-GA-01-0000372
Key People
Krishna Gopal Gupta Managing Director Cedric Lobo Whole-Time Director Vikram Gupta Director Recognitions & Rankings of GKB Ophthalmics
Contact details
GKB Ophthalmics Limited's registered office is in Mapusa, Goa. Its website is gkb.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address16A Tivim Industrial Estate Mapusa, Goa, India – 403526
- IndustryHome & Lifestyle, Lifestyle Products & Accessories Manufacturing
To see the full contact details of GKB Ophthalmics Limited, buy the company report.
Comprehensive company report
GKB Ophthalmics Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
GKB Ophthalmics operates one associated brand: GKB Ophthalmics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of ophthalmic lenses for global export | gkb.net |
Business activity
The main business activity of GKB Ophthalmics is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of GKB Ophthalmics Limited, buy the company report.
Financials of GKB Ophthalmics Limited
FY 2025-26 filings availableGKB Ophthalmics Limited reported revenue of ₹149.06 Cr (up 36.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue
₹149 Cr
+36.8% YoY
EBITDA
₹6.77 Cr
+343.5% YoY
Profit After Tax
₹2.75 Cr
+138.8% YoY
Net Worth
₹52.83 Cr
+1.2% YoY
Total Assets
₹71.06 Cr
-4.3% YoY
Total Debt
₹11.66 Cr
-19.6% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 149 | 109 | 88.25 | 75.47 | 70.94 | 56.88 | 58.53 |
| Revenue growth | +36.8% | +23.5% | +16.9% | +6.4% | +24.7% | -2.8% | - |
| EBITDA | 6.77 | (2.78) | 0.51 | 3.69 | 4.85 | 1.59 | 2.14 |
| EBITDA margin | +4.5% | -2.6% | +0.6% | +4.9% | +6.8% | +2.8% | +3.7% |
| Profit before tax | 3.10 | (6.73) | (2.78) | 0.15 | 1.95 | (0.92) | (1.83) |
| Net profit | 2.75 | (7.09) | (2.86) | (0.13) | 1.32 | 0.11 | (1.84) |
| Net profit margin | +1.8% | -6.5% | -3.2% | -0.2% | +1.9% | +0.2% | -3.1% |
| EPS (₹) | 2.22 | (13.98) | (5.58) | (0.33) | 2.53 | (1.80) | (3.65) |
| Balance sheet | |||||||
| Total assets | 71.06 | 74.24 | 78.71 | 81.04 | 81.44 | 79.50 | 75.55 |
| Net worth | 52.83 | 52.19 | 59.77 | 62.69 | 63.10 | 62.65 | 59.25 |
| Total debt | 11.66 | 14.50 | 11.49 | 11.22 | 11.75 | 11.97 | 15.16 |
| Cash & bank | 4.90 | 13.82 | 17.84 | 14.45 | 16.40 | 17.28 | 13.87 |
| Net working capital | 46.86 | 48.42 | 51.69 | 52.48 | 46.98 | 46.54 | 46.53 |
| Cash flow | |||||||
| Cash from operations | (3.81) | (3.43) | 4.22 | (2.77) | 5.07 | 6.86 | 3.27 |
| Cash from investing | 9.00 | 2.55 | (1.71) | 1.43 | (3.52) | (16.78) | (3.73) |
| Cash from financing | (5.55) | 0.67 | (1.64) | (2.19) | (1.66) | 2.77 | 4.30 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.04 | 29.79 | 56.79 | 30.17 | 32.31 | 31.02 | 25.80 | 26.14 |
| Revenue growth (YoY) | +2.3% | -4.0% | +120.1% | +15.4% | +24.2% | - | - | - |
| Other income | 0.73 | 0.81 | 0.87 | 0.37 | 0.21 | 0.35 | 0.48 | 0.28 |
| EBITDA | 2.63 | 1.59 | 1.36 | 3.02 | 0.80 | (2.86) | (0.95) | (0.06) |
| EBITDA margin | +8.0% | +5.3% | +2.4% | +10.0% | +2.5% | -9.2% | -3.7% | -0.2% |
| Depreciation | 0.80 | 0.80 | 0.82 | 0.82 | 0.80 | 0.80 | 0.77 | 0.77 |
| Interest | 0.51 | 0.52 | 0.73 | 0.66 | 0.77 | 0.63 | 0.63 | 0.55 |
| Profit before tax | 2.05 | 1.08 | 0.68 | 1.91 | (0.56) | (3.94) | (1.87) | (1.10) |
| Tax | 0.20 | (0.04) | (0.03) | 0.07 | 0.08 | 0.19 | 0.05 | 0.06 |
| Net profit | 1.85 | 1.12 | 0.71 | 1.84 | (0.64) | (4.13) | (1.92) | (1.16) |
| EPS (₹) | 2.00 | 0.38 | 0.08 | 3.17 | (2.02) | (7.03) | (4.03) | (2.41) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 25.64 | 32.75 | 31.18 | 27.73 | 27.05 | 21.34 | 25.56 |
| Revenue growth | -21.7% | +5.0% | +12.4% | +2.5% | +26.8% | -16.5% | - |
| EBITDA | (4.75) | (3.47) | (1.28) | (1.10) | (0.44) | (1.30) | (0.72) |
| EBITDA margin | -18.5% | -10.6% | -4.1% | -4.0% | -1.6% | -6.1% | -2.8% |
| Profit before tax | (3.64) | (6.03) | (3.38) | (3.05) | (2.31) | (2.29) | (4.16) |
| Net profit | (1.94) | (6.14) | (3.46) | (2.95) | (2.27) | (1.10) | (4.17) |
| Net profit margin | -7.6% | -18.8% | -11.1% | -10.6% | -8.4% | -5.2% | -16.3% |
| EPS (₹) | (7.08) | (12.12) | (6.78) | (5.72) | (4.58) | (4.18) | (8.28) |
| Balance sheet | |||||||
| Total assets | 27.94 | 38.24 | 38.00 | 41.62 | 44.90 | 46.55 | 46.04 |
| Net worth | 14.32 | 17.67 | 23.99 | 27.52 | 30.40 | 32.77 | 35.25 |
| Total debt | 9.54 | 18.09 | 11.08 | 11.22 | 11.75 | 11.97 | 10.04 |
| Cash & bank | 2.23 | 0.89 | 0.70 | 0.41 | 1.43 | 2.10 | 10.36 |
| Net working capital | 8.35 | 5.44 | 3.86 | 5.89 | 5.22 | 8.02 | 16.47 |
| Cash flow | |||||||
| Cash from operations | (1.48) | (5.04) | 1.36 | (1.14) | 2.33 | 2.11 | 6.13 |
| Cash from investing | 12.21 | (0.16) | 0.37 | 2.40 | (0.83) | (11.52) | (5.68) |
| Cash from financing | (10.72) | 5.12 | (1.74) | (2.03) | (1.50) | 0.61 | 3.31 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.40 | 6.40 | 4.36 | 6.11 | 8.77 | 8.43 | 7.45 | 8.26 |
| Revenue growth (YoY) | -27.0% | -24.1% | -41.5% | -26.0% | +1.7% | - | - | - |
| Other income | 0.47 | 0.99 | 3.54 | 1.37 | 0.07 | 0.01 | 1.81 | 0.06 |
| Total expenses | 6.66 | 8.34 | 5.71 | 6.73 | 9.62 | 9.61 | 8.27 | 9.30 |
| EBITDA | (0.26) | (1.94) | (1.35) | (0.62) | (0.85) | (1.18) | (0.82) | (1.04) |
| EBITDA margin | -4.1% | -30.3% | -31.0% | -10.1% | -9.7% | -14.0% | -11.0% | -12.6% |
| Depreciation | 0.66 | 0.66 | 0.68 | 0.68 | 0.67 | 0.66 | 0.67 | 0.66 |
| Interest | 0.30 | 0.32 | 0.60 | 0.57 | 0.68 | 0.60 | 0.48 | 0.40 |
| Profit before tax | (0.75) | (1.93) | 0.91 | (0.50) | (2.13) | (2.43) | (0.16) | (2.04) |
| Tax | (0.24) | (0.04) | (0.07) | 0.02 | 0.02 | 0.04 | 0.01 | 0.01 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 28 Oct 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.04 | 29.79 | 56.79 | 30.17 | 32.31 | 31.02 | 25.80 | 26.14 |
| Revenue growth (YoY) | +2.3% | -4.0% | +120.1% | +15.4% | +24.2% | - | - | - |
| Other income | 0.73 | 0.81 | 0.87 | 0.37 | 0.21 | 0.35 | 0.48 | 0.28 |
| EBITDA | 2.63 | 1.59 | 1.36 | 3.02 | 0.80 | (2.86) | (0.95) | (0.06) |
| EBITDA margin | +8.0% | +5.3% | +2.4% | +10.0% | +2.5% | -9.2% | -3.7% | -0.2% |
| Depreciation | 0.80 | 0.80 | 0.82 | 0.82 | 0.80 | 0.80 | 0.77 | 0.77 |
| Interest | 0.51 | 0.52 | 0.73 | 0.66 | 0.77 | 0.63 | 0.63 | 0.55 |
| Profit before tax | 2.05 | 1.08 | 0.68 | 1.91 | (0.56) | (3.94) | (1.87) | (1.10) |
| Tax | 0.20 | (0.04) | (0.03) | 0.07 | 0.08 | 0.19 | 0.05 | 0.06 |
| Net profit | 1.85 | 1.12 | 0.71 | 1.84 | (0.64) | (4.13) | (1.92) | (1.16) |
| EPS (₹) | 2.00 | 0.38 | 0.08 | 3.17 | (2.02) | (7.03) | (4.03) | (2.41) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 149 | 109 | 88.25 | 75.47 | 70.94 | 56.88 | 58.53 |
| Revenue growth | +36.8% | +23.5% | +16.9% | +6.4% | +24.7% | -2.8% | - |
| Other income | 2.24 | 1.51 | 1.51 | 0.96 | 1.25 | 2.66 | 1.11 |
| Total expenses | 142 | 112 | 87.74 | 71.78 | 66.09 | 55.29 | 56.39 |
| Employee cost | 16.11 | 17.26 | 13.76 | 11.15 | 9.49 | 7.86 | 8.10 |
| EBITDA | 6.77 | (2.78) | 0.51 | 3.69 | 4.85 | 1.59 | 2.14 |
| EBITDA margin | +4.5% | -2.6% | +0.6% | +4.9% | +6.8% | +2.8% | +3.7% |
| Depreciation | 3.24 | 3.09 | 2.90 | 2.83 | 2.67 | 3.14 | 3.62 |
| Interest | 2.67 | 2.37 | 1.90 | 1.67 | 1.48 | 2.03 | 1.46 |
| Profit before tax | 3.10 | (6.73) | (2.78) | 0.15 | 1.95 | (0.92) | (1.83) |
| Tax | 0.07 | 0.35 | 0.21 | 0.02 | 0.00 | (0.18) | 0.00 |
| Net profit | 2.75 | (7.09) | (2.86) | (0.13) | 1.32 | 0.11 | (1.84) |
| Net profit margin | +1.8% | -6.5% | -3.2% | -0.2% | +1.9% | +0.2% | -3.1% |
| EPS (₹) | 2.22 | (13.98) | (5.58) | (0.33) | 2.53 | (1.80) | (3.65) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 |
| Reserves & surplus | 47.79 | 47.15 | 54.73 | 57.65 | 58.06 | 57.61 | 54.21 |
| Shareholders' funds (net worth) | 52.83 | 52.19 | 59.77 | 62.69 | 63.10 | 62.65 | 59.25 |
| Minority interest | 2.05 | 4.24 | 4.43 | 4.60 | 4.32 | 3.65 | 0.00 |
| Secured loans | 10.41 | 12.06 | 11.49 | 11.22 | 11.75 | 11.32 | 10.04 |
| Unsecured loans | 1.25 | 2.44 | 0.00 | 0.00 | 0.00 | 0.65 | 5.12 |
| Total debt | 11.66 | 14.50 | 11.49 | 11.22 | 11.75 | 11.97 | 15.16 |
| Total liabilities | 71.06 | 74.24 | 78.71 | 81.04 | 81.44 | 79.50 | 75.55 |
| Assets | |||||||
| Gross block | 50.31 | 48.90 | 48.03 | 46.03 | 46.77 | 45.78 | 52.62 |
| Net block | 15.01 | 17.03 | 18.21 | 19.03 | 22.65 | 23.76 | 26.33 |
| Capital work in progress | 3.78 | 3.91 | 3.91 | 3.95 | 3.41 | 1.23 | 0.00 |
| Investments | 1.95 | 2.01 | 1.83 | 1.89 | 1.97 | 2.08 | 1.15 |
| Inventories | 54.63 | 50.38 | 40.02 | 38.74 | 37.70 | 35.41 | 30.63 |
| Sundry debtors | 44.87 | 25.49 | 28.40 | 27.74 | 19.51 | 19.48 | 24.92 |
| Cash & bank balances | 4.90 | 13.82 | 17.84 | 14.45 | 16.40 | 17.28 | 13.87 |
| Loans & advances | 3.57 | 9.70 | 1.22 | 2.60 | 1.92 | 1.51 | 3.54 |
| Total current assets | 108 | 99.39 | 87.48 | 83.53 | 75.53 | 73.68 | 72.96 |
| Total current liabilities | 61.11 | 50.97 | 35.79 | 31.05 | 28.55 | 27.14 | 26.43 |
| Net working capital | 46.86 | 48.42 | 51.69 | 52.48 | 46.98 | 46.54 | 46.53 |
| Total assets | 71.06 | 74.24 | 78.71 | 81.04 | 81.44 | 79.50 | 75.55 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 3.02 | 3.23 | 2.36 | 5.89 | 6.01 | 13.17 | 9.33 |
| Net cash from operating activities | (3.81) | (3.43) | 4.22 | (2.77) | 5.07 | 6.86 | 3.27 |
| Net cash from investing activities | 9.00 | 2.55 | (1.71) | 1.43 | (3.52) | (16.78) | (3.73) |
| Net cash from financing activities | (5.55) | 0.67 | (1.64) | (2.19) | (1.66) | 2.77 | 4.30 |
| Net change in cash | (0.35) | (0.21) | 0.87 | (3.53) | (0.12) | (7.15) | 3.84 |
| Closing cash | 4.90 | 13.82 | 17.84 | 14.45 | 16.40 | 17.28 | 13.87 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +36.8% | +23.5% | +16.9% | +6.4% | +24.7% | -2.8% | - |
| EBITDA growth | +343.5% | -645.1% | -86.2% | -23.9% | +205.0% | -25.7% | - |
| PBT growth | +9998.0% | -142.1% | - | -92.3% | +9998.0% | +49.7% | -15.1% |
| Net income growth | +138.8% | -147.9% | -2100.0% | -109.9% | +1100.0% | +106.0% | - |
| Revenue CAGR (3Y) | +25.5% | +15.4% | +15.8% | +8.8% | +7.5% | -10.0% | -8.5% |
| EBITDA CAGR (3Y) | +22.4% | - | -31.6% | +19.9% | +62.5% | +5.9% | +5.4% |
| Profitability & leverage | |||||||
| Net income margin | +2.0% | -6.5% | -3.4% | +0.2% | +2.8% | -1.3% | -3.1% |
| Return on capital employed | +10.8% | -6.0% | -1.2% | +2.3% | +4.5% | +2.8% | -0.5% |
| Return on net worth | +8.9% | -12.7% | -4.9% | +0.2% | +3.1% | +0.4% | -3.2% |
| Debt / equity | 0.25 | 0.23 | 0.19 | 0.18 | 0.19 | 0.22 | 0.26 |
| Long-term debt / equity | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 |
| Interest cover | 75.64 | -40.37 | -79.50 | 194.19 | 67.89 | -130.97 | -98.65 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 3.00 | 2.25 | 1.88 | 1.63 | 1.53 | 1.16 | 1.16 |
| Inventory turnover | 2.84 | 2.41 | 2.24 | 1.97 | 1.94 | 1.72 | 1.99 |
| Debtors turnover | 4.24 | 4.04 | 3.14 | 3.19 | 3.64 | 2.56 | 2.42 |
| EPS (₹) | 2.22 | (13.98) | (5.58) | (0.33) | 2.53 | (1.80) | (3.65) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 104.82 | 103.55 | 118.58 | 124.38 | 125.17 | 124.30 | 117.55 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.40 | 6.40 | 4.36 | 6.11 | 8.77 | 8.43 | 7.45 | 8.26 |
| Revenue growth (YoY) | -27.0% | -24.1% | -41.5% | -26.0% | +1.7% | - | - | - |
| Other income | 0.47 | 0.99 | 3.54 | 1.37 | 0.07 | 0.01 | 1.81 | 0.06 |
| Total expenses | 6.66 | 8.34 | 5.71 | 6.73 | 9.62 | 9.61 | 8.27 | 9.30 |
| EBITDA | (0.26) | (1.94) | (1.35) | (0.62) | (0.85) | (1.18) | (0.82) | (1.04) |
| EBITDA margin | -4.1% | -30.3% | -31.0% | -10.1% | -9.7% | -14.0% | -11.0% | -12.6% |
| Depreciation | 0.66 | 0.66 | 0.68 | 0.68 | 0.67 | 0.66 | 0.67 | 0.66 |
| Interest | 0.30 | 0.32 | 0.60 | 0.57 | 0.68 | 0.60 | 0.48 | 0.40 |
| Profit before tax | (0.75) | (1.93) | 0.91 | (0.50) | (2.13) | (2.43) | (0.16) | (2.04) |
| Tax | (0.24) | (0.04) | (0.07) | 0.02 | 0.02 | 0.04 | 0.01 | 0.01 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 25.64 | 32.75 | 31.18 | 27.73 | 27.05 | 21.34 | 25.56 |
| Revenue growth | -21.7% | +5.0% | +12.4% | +2.5% | +26.8% | -16.5% | - |
| Other income | 5.97 | 1.97 | 2.08 | 2.09 | 1.96 | 3.34 | 1.38 |
| Total expenses | 30.39 | 36.22 | 32.46 | 28.83 | 27.49 | 22.64 | 26.28 |
| Employee cost | 9.67 | 10.88 | 9.22 | 7.45 | 6.92 | 5.81 | 6.21 |
| EBITDA | (4.75) | (3.47) | (1.28) | (1.10) | (0.44) | (1.30) | (0.72) |
| EBITDA margin | -18.5% | -10.6% | -4.1% | -4.0% | -1.6% | -6.1% | -2.8% |
| Depreciation | 2.69 | 2.64 | 2.59 | 2.54 | 2.49 | 2.99 | 3.47 |
| Interest | 2.17 | 1.89 | 1.59 | 1.50 | 1.34 | 1.34 | 1.35 |
| Profit before tax | (3.64) | (6.03) | (3.38) | (3.05) | (2.31) | (2.29) | (4.16) |
| Tax | (0.08) | 0.07 | 0.04 | (0.16) | 0.00 | (0.18) | 0.00 |
| Net profit | (1.94) | (6.14) | (3.46) | (2.95) | (2.27) | (1.10) | (4.17) |
| Net profit margin | -7.6% | -18.8% | -11.1% | -10.6% | -8.4% | -5.2% | -16.3% |
| EPS (₹) | (7.08) | (12.12) | (6.78) | (5.72) | (4.58) | (4.18) | (8.28) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 |
| Reserves & surplus | 9.28 | 12.63 | 18.95 | 22.48 | 25.36 | 27.73 | 30.21 |
| Shareholders' funds (net worth) | 14.32 | 17.67 | 23.99 | 27.52 | 30.40 | 32.77 | 35.25 |
| Secured loans | 8.84 | 11.48 | 11.53 | 11.22 | 11.75 | 11.32 | 10.04 |
| Unsecured loans | 0.70 | 6.61 | (0.45) | 0.00 | 0.00 | 0.65 | 0.00 |
| Total debt | 9.54 | 18.09 | 11.08 | 11.22 | 11.75 | 11.97 | 10.04 |
| Total liabilities | 27.94 | 38.24 | 38.00 | 41.62 | 44.90 | 46.55 | 46.04 |
| Assets | |||||||
| Gross block | 44.14 | 43.42 | 42.66 | 41.58 | 43.17 | 42.35 | 49.22 |
| Net block | 12.49 | 14.44 | 15.90 | 17.28 | 21.27 | 22.28 | 24.83 |
| Capital work in progress | 3.78 | 3.78 | 3.78 | 3.82 | 3.29 | 1.23 | 0.00 |
| Investments | 0.19 | 11.90 | 11.90 | 11.90 | 11.90 | 12.22 | 3.21 |
| Inventories | 5.18 | 6.08 | 4.69 | 6.06 | 5.34 | 6.98 | 4.70 |
| Sundry debtors | 5.18 | 7.49 | 6.86 | 4.88 | 6.00 | 7.44 | 10.37 |
| Cash & bank balances | 2.23 | 0.89 | 0.70 | 0.41 | 1.43 | 2.10 | 10.36 |
| Loans & advances | 4.42 | 2.22 | 2.00 | 2.08 | 1.28 | 1.63 | 1.20 |
| Total current assets | 17.01 | 16.68 | 14.25 | 13.43 | 14.05 | 18.15 | 26.63 |
| Total current liabilities | 8.66 | 11.24 | 10.39 | 7.54 | 8.83 | 10.13 | 10.16 |
| Net working capital | 8.35 | 5.44 | 3.86 | 5.89 | 5.22 | 8.02 | 16.47 |
| Total assets | 27.94 | 38.24 | 38.00 | 41.62 | 44.90 | 46.55 | 46.04 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.00 | 0.07 | 0.07 | 0.85 | 0.85 | 9.65 | 5.89 |
| Net cash from operating activities | (1.48) | (5.04) | 1.36 | (1.14) | 2.33 | 2.11 | 6.13 |
| Net cash from investing activities | 12.21 | (0.16) | 0.37 | 2.40 | (0.83) | (11.52) | (5.68) |
| Net cash from financing activities | (10.72) | 5.12 | (1.74) | (2.03) | (1.50) | 0.61 | 3.31 |
| Net change in cash | 0.00 | (0.07) | 0.00 | (0.78) | 0.00 | (8.80) | 3.76 |
| Closing cash | 2.23 | 0.89 | 0.70 | 0.41 | 1.43 | 2.10 | 10.36 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -21.7% | +5.0% | +12.4% | +2.5% | +26.8% | -16.5% | - |
| EBITDA growth | -36.9% | -171.1% | -16.4% | -150.0% | +66.2% | -80.6% | - |
| PBT growth | +39.6% | -78.4% | -10.8% | -32.0% | -0.9% | +45.0% | -27.6% |
| Net income growth | +68.4% | -77.5% | -17.3% | -30.0% | -106.4% | +73.6% | - |
| Revenue CAGR (3Y) | -2.6% | +6.6% | +13.5% | +2.8% | -3.9% | -17.1% | -14.3% |
| EBITDA CAGR (3Y) | +62.8% | +99.1% | -0.5% | +15.2% | -25.4% | +9.5% | +17.8% |
| Profitability & leverage | |||||||
| Net income margin | -13.9% | -18.6% | -11.0% | -10.4% | -8.5% | -9.9% | -16.3% |
| Return on capital employed | 0.0% | 0.0% | 0.0% | 0.0% | -2.1% | +0.1% | -6.2% |
| Return on net worth | 0.0% | 0.0% | 0.0% | 0.0% | -7.3% | -3.2% | -11.9% |
| Debt / equity | 0.86 | 0.71 | 0.44 | 0.40 | 0.38 | 0.32 | 0.29 |
| Long-term debt / equity | 0.26 | 0.20 | 0.04 | 0.05 | 0.04 | 0.01 | 0.00 |
| Interest cover | -29.17 | -30.93 | -41.09 | -41.21 | -45.73 | -31.24 | -32.22 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.59 | 0.76 | 0.74 | 0.65 | 0.63 | 0.47 | 0.54 |
| Inventory turnover | 4.55 | 6.08 | 5.80 | 4.86 | 4.39 | 3.65 | 4.45 |
| Debtors turnover | 4.05 | 4.56 | 5.31 | 5.10 | 4.03 | 2.40 | 2.41 |
| EPS (₹) | (7.08) | (12.12) | (6.78) | (5.72) | (4.58) | (4.18) | (8.28) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 28.42 | 35.06 | 47.59 | 54.59 | 60.32 | 65.01 | 69.93 |
To see the full year-wise statements and ratios of GKB Ophthalmics Limited, buy the company report.
Board of directors of GKB Ophthalmics Limited
GKB Ophthalmics has 6 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Gopal Gupta Also directs: GKB Vision Private Limited | Managing Director | 02 Jul 1982 | 44 Years 3 Months | Current |
| Vikram Gupta Also directs: GKB Vision Private Limited, Forever Now LLP | Director | 24 Jul 1996 | 30 Years 3 Months | Current |
| Cedric Lobo | Whole-Time Director | 01 Jun 2024 | 2 Years 4 Months | Current |
| Ninad Gurudas Kamat Also directs: The Southern Gas Limited | Director | 01 Jun 2024 | 2 Years 4 Months | Current |
| Sandhya Ajit Kamat | Director | 22 May 2024 | 2 Years 5 Months | Current |
| Purushottam Sitaram Mantri Also directs: The Southern Gas Limited, De Nora India Limited | Director | 20 Jun 2023 | 3 Years 4 Months | Current |
Auditor
GKB Ophthalmics Limited is audited by M S K A & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S K A & Associates | FY 2023 | 105047W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 51.20%, foreign institutional investors hold 1.80%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 47.10%.
Sep 2026
QUARTER
51.20% Promoters
1.80% FII (Foreign Institutional)
47.10% Retail & Others
Promoter holding - history
Now 51.20% · Sep 2026High 51.20% · Sep 2026Low 51.10% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 51.20% | 51.10% | 51.10% | 51.10% |
| Public | 48.80% | 48.90% | 48.90% | 48.90% |
Charges & borrowings
Open charges
₹14.44 Cr
Satisfied charges
₹8.06 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jul 2010 | 10236590 | Others | ₹5.7 Cr | Open | |
| 12 May 1995 | 90076691 | State Bank of India | ₹8.74 Cr | Open | |
| 15 Oct 2015 | 10607579 | The Saraswat Co-Operative Bank Limited | ₹10 Lakh | Satisfied | |
| 16 May 2011 | 10295069 | Canara Bank | ₹2 Cr | Satisfied | |
| 14 May 2010 | 10223768 | Pyramid Finance Private Limited | ₹40 Lakh | Satisfied |
To see the full charge records of GKB Ophthalmics Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
GKB Ophthalmics Limited has 29 deals on record (29 market trades); the latest was in September 2026.
Total deals
29
Market trades
29
Deals on record (5 of 29)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2026 | Market trade | ₹23.5 Lakh | Seller: Dhwaja Commodity Services Private Limited |
| Apr 2024 | Market trade | ₹1.1 Cr | Buyer: an individual Seller: Counter Cyclical Investments Private Limited , an individual |
| Dec 2022 | Market trade | ₹69.3 Lakh | Buyer: Rajasthan Global Securities Private Limited Seller: an individual |
| Jun 2021 | Market trade | ₹48.4 Lakh | Buyer: Raviraj Developers Limited |
| Nov 2019 | Market trade | ₹30.3 Lakh | Buyer: an individual Seller: HDFC Bank Limited |
To see the full deal history of GKB Ophthalmics Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
GKB Ophthalmics Limited has 19 court cases on record: 11 filed by GKB Ophthalmics, 8 filed against it. 4 cases are pending and 15 are disposed.
Total cases
19
Filed by the company
11
Filed against the company
8
Pending
4
Disposed
15
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 12 | 6 | 3 |
| District courts | 6 | 1 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against an individual | Pending |
| High Court, GOA | Writ petition | Filed by the company against an individual | Pending |
| Bombay High Court | Writ petition | Filed by the company against an individual | Pending |
| District court, North Goa, Goa | Court case (SCS) | Filed by the company against an individual | Pending |
| District court, North Goa, Goa | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of GKB Ophthalmics Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
GKB Ophthalmics Limited was last rated by Crisil on 29 Oct 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 29 Oct 2020 |
To see the full credit ratings and regulatory alerts of GKB Ophthalmics Limited, buy the company report.
MSME payment delays
GKB Ophthalmics Limited has 17 MSME Form 1 returns on record between 2019 and 2024, listing 1,966 overdue payments to 92 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 92)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Tanmay Enterprises | |||
| Sahyadri Offset System | |||
| Jaineeket Enterprises (Goa) |
To see the full MSME payment records of GKB Ophthalmics Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
GKB Ophthalmics has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| GSV Ophthalmics Private Limited | U36990GA2018PTC013725 |
To see the full group structure of GKB Ophthalmics Limited, buy the company report.
GST
GKB Ophthalmics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AAACG7070R1ZE | Goa | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of GKB Ophthalmics Limited, buy the company report.
Recent activity
GKB Ophthalmics Limited has 34 board changes on record since 1981: 20 appointments and 14 cessations. The latest: Shashi Kumar Katreddi ceased to be Director on 31 Mar 2025.
Filing
Gkb Ophthalmics Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Goa.
AGM
Gkb Ophthalmics Limited last Annual general meeting of members was held on 21 Aug 2025 as per latest MCA records.
Ceased
Shashi Kumar Katreddi ceased to be Director.
Appointed
Cedric Lobo was appointed as Whole-Time Director.
Appointed
Ninad Gurudas Kamat was appointed as Director.
Ceased
Anil Vithal Palekar ceased to be Director.
Appointed
Sandhya Ajit Kamat was appointed as Director.
Charges
A charge with Others of Rs. 5.70 Cr registered on 19 Jul 2010 with Charge ID 10236590 was modified on 19 Mar 2024.
Ceased
Subhash Sadashiv Redkar ceased to be Director.
Appointed
Purushottam Sitaram Mantri was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 8.74 Cr registered on 12 May 1995 with Charge ID 90076691 was modified on 30 May 2023.
Ceased
Sadashiv Vasudev Shet ceased to be Director.
42 earlier events are in the company report.
News
Frequently asked questions
GKB Ophthalmics is an active public limited company based in Mapusa, Goa, India. The company works in lifestyle products and accessories manufacturing, within the home and lifestyle industry. It was incorporated on 10 December 1981 (45+ years old) and is registered under CIN L26109GA1981PLC000469. Listed on BSE: 533212 and NSE: GKB.
GKB Ophthalmics reported revenue of ₹149.06 Cr for FY 2025-26 (up 36.8% YoY) based on consolidated financials.
GKB Ophthalmics has 6 current directors:
- Krishna Gopal Gupta - Managing Director
- Cedric Lobo - Whole-Time Director
- Vikram Gupta - Director
- Ninad Gurudas Kamat - Director
- Sandhya Ajit Kamat - Director
- Purushottam Sitaram Mantri - Director
The latest financial statements of GKB Ophthalmics on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 21 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of GKB Ophthalmics is 30AAACG7070R1ZE, registered in Goa.
The CIN (Corporate Identification Number) of GKB Ophthalmics is L26109GA1981PLC000469. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. GKB Ophthalmics is a listed company as per MCA records. Its shares are listed on both BSE (code: 533212) and NSE (symbol: GKB).
GKB Ophthalmics has 19 court cases on record: 11 filed by the company and 8 filed against it. 4 are pending. Most are in the high courts.
GKB Ophthalmics was incorporated on 10 December 1981, making it 45+ years old. It is registered with the Registrar of Companies, Goa.
GKB Ophthalmics has 29 deals on record (29 market trades); the latest was in September 2026.
Shashi Kumar Katreddi ceased to be Director on 31 Mar 2025. Cedric Lobo was appointed as Whole-Time Director on 01 Jun 2024. Ninad Gurudas Kamat was appointed as Director on 01 Jun 2024. GKB Ophthalmics has 34 board changes on record in total.